Clinical Trials Browser

Phase 2 × Interventional × Antigens, CD19 × Clear all

NCT02846584 2016-09-07

a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse